key: cord-0717865-adozx344
authors: Eaglesham, James B.; Kranzusch, Philip J.
title: Conserved strategies for pathogen evasion of cGAS-STING immunity
date: 2020-04-15
journal: Curr Opin Immunol
DOI: 10.1016/j.coi.2020.04.002
sha: ebb03b46a514176b9082a97579c1761ba5077f7e
doc_id: 717865
cord_uid: adozx344

Abstract The cGAS-STING pathway of cytosolic DNA sensing allows mammalian cells to detect and respond to infection with diverse pathogens. Pathogens in turn encode numerous factors that inhibit nearly all steps of cGAS-STING signal transduction. From masking of cytosolic DNA ligands, to post-translational modification of cGAS and STING, and degradation of the nucleotide second messenger 2′3′-cGAMP, pathogens have evolved convergent mechanisms to evade cGAS-STING sensing. Here we examine pathogen inhibitors of innate immunity in the context of newly discovered regulatory features controlling cellular cGAS-STING activation. Comparative analysis of these strategies provides insight into mechanisms of action and suggests aspects of cGAS-STING regulation and immune evasion that remain to be discovered.

The cGAS-STING pathway detects cytosolic DNA and triggers a robust immune 13 response that restricts replication of diverse pathogens. The enzyme cyclic GMP-AMP 14 synthase (cGAS) directly senses cytosolic DNA and catalyzes synthesis of the nucleotide 15 second messenger 2′3′-cGAMP [1] [2] [3] [4] [5] . 2′3′-cGAMP diffuses throughout the cell and binds to 16

Stimulator of Interferon Genes (STING), a signaling adapter which oligomerizes and traffics 17 from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC), 18 where it drives downstream innate immune responses through the type I interferon and NF-κB 19 pathways to inhibit pathogen infection [6] [7] [8] [9] [10] . 20

Activation of type I interferon and inflammatory signaling by cGAS-STING during 21 infection places diverse bacterial and viral pathogens under selective pressure to disable this 22 pathway. While the genomes of DNA viruses and bacteria may serve to directly activate cGAS, 23 damage to the mitochondria during infection with RNA viruses can also trigger cGAS activation 24 through exposure of mitochondrial DNA [11] . Therefore, pathogens from divergent groups 25 encode proteins targeting cGAS, 2′3′-cGAMP, and STING to disrupt signaling. Despite the great 26 diversity of these pathogens and the effectors they employ to restrict cGAS-STING activation, 27 shared strategies can be identified which allow escape from the innate immune response 28 ( Figure 1) . 29

Within the past two years, major advances have expanded our understanding of the 30 mechanism of cGAS-STING signal transduction, providing new insight into how different viral 31 and bacterial factors restrict signaling. In particular, formation of higher-order phase-separated 32 droplets has emerged as a checkpoint for regulating cGAS activation [12] , new structures of 33 STING in complex with TBK1 have provided a mechanism for assembly of the STING 34 signalosome and activation of downstream signaling [13, 14] , and extracellular 2′3′-cGAMP 35 signaling has emerged as an entirely new facet of cGAS-STING biology [15, 16] . While other 36 J o u r n a l P r e -p r o o f 4 recent reviews provide in-depth analysis of these new discoveries [17, 18] , here we focus on 37 conserved strategies utilized by different pathogens for evasion of cGAS-STING immunity. 38

Study of these strategies has provided important insight into cellular regulation of cGAS-STING 39 signaling, and likewise these pathogen immune escape factors will continue to serve as useful 40 tools to gain mechanistic insight into pathway function and regulation. In turn, our deepening In order to productively infect a target cell, viruses and intracellular bacteria utilize 47 diverse techniques to prevent activation of cGAS before they initiate replication ( Figure 2 In the event that viral DNA is exposed in the cytosol prior to replication and gene 62 expression, the nuclear-replicating herpesviruses carry immune antagonists directly within the 63 viral particle to disable DNA sensing after infection. Herpes simplex virus 1 (HSV-1) VP22 and 64 human cytomegalovirus (HCMV) UL83 are both tegument proteins which bind cGAS and block 65 downstream signaling [23, 24] . Another member of the Herpesviridae, Kaposi's sarcoma-66 associated herpesvirus (KSHV), also encodes a tegument protein that inhibits cGAS, ORF52 67 (also named KicGAS) [25] . ORF52 blocks cGAS activation through a mechanism which requires 68 both cGAS and DNA binding by ORF52. While these proteins from diverse herpesviruses 69 seemingly vary in their requirement for DNA binding activity, they share striking similarities in 70 that each is carried within the virion to bind cGAS and block immune activation after infection. 71 HCMV expresses two additional proteins which interfere with cGAS-DNA binding and formation 72 of higher-order complexes, UL31 and UL42 [26, 27] . Likewise, cytoplasmic isoforms of the KSHV 73 LANA protein have been shown to bind cGAS, and block downstream signaling [28] . Given new 74 data demonstrating that cGAS phase separates with DNA, it is tempting to speculate that some 75 or all of these proteins interfere individually or collaboratively with multivalent cGAS-DNA 76 binding, thus restricting phase separation and altering the balance of innate immune sensing in 77 favor of viral replication. 78

Pathogens also target cGAS through post-translational modification, resulting in 79 impaired 2′3′-cGAMP synthesis. A second HSV-1 tegument protein, UL37, was recently 80 Streptococcus species enzymatically cleave cyclic dinucleotide molecules. Initially, these 105 proteins were reported to cleave bacterial cyclic dinucleotides like cyclic di-AMP to avoid host 106 immune recognition, as these endogenous bacterial signaling molecules can also be sensed by 107 STING as pathogen-associated molecular patterns [10, 37, 38] . However, the Mycobacterium 108 tuberculosis CdnP enzyme exhibits activity toward host 2′3′-cGAMP as well as bacterial cyclic 109 di-AMP, indicating that it may serve a dual function in infection to prevent host recognition of 110 bacterial cyclic di-AMP as well as degradation of host 2′3′-cGAMP [39] . 111

Similarly, VACV and other related poxviruses encode a nuclease called poxvirus 112 immune nuclease (poxin) which degrades 2′3′-cGAMP in order to prevent activation of the cGAS-STING pathway [33] . Poxin is highly specific for host 2′3′-cGAMP, and deletion of poxin 114 from the viral genome resulted in attenuation of VACV in a mouse model of infection. Functional 115 poxin enzymes are also found in the genomes of insect viruses in the family Baculoviridae, and 116 moths and butterflies, which serve as hosts to these viruses [33] . The emerging role for cGAS-117 STING signaling in insects is likely to enable discovery of additional insect pathogen inhibitors of 118 pathway activation [40] [41] [42] . In mammals, no cytosolic enzymes have been discovered which 119 degrade 2′3′-cGAMP, but instead the extracellular enzyme ectonucleotide 120 pyrophosphatase/phosphodiesterase family member 1 (ENPP1) has been shown to be the 121 major source of 2′3′-cGAMP-degrading activity in mammalian tissue and plasma [43] . 122

Interestingly, avian poxviruses lack a homolog of poxin, but do encode a predicted homolog of 123 ENPP1, indicating these viruses may have obtained alternative means of degrading 2′3′-cGAMP 124 during infection [44] . Together, these results indicate that 2′3′-cGAMP degradation is a more 125 widespread mechanism for control of innate immune signaling than previously understood. 126

Given that 2′3′-cGAMP can be passed between cells through gap junctions, and infiltrate 127 nascent virions [34] [35] [36] , future study is required to understand if pathogens possess specific 128 mechanisms for blocking these unique aspects of 2′3′-cGAMP biology. Recent studies showed 129 that 2′3′-cGAMP can be exported from cells by an unknown transporter and imported into 130 immune cells through the reduced folate transporter SLC19A1 to activate an immune response 131 [15, 16] . This indicates that 2′3′-cGAMP import and export may also be important steps at which 132 viruses and bacteria interfere to gain the upper hand during infection. 133

Several viruses employ strategies to degrade STING to prevent its activation by 2′3′-136 cGAMP ( Figure 4 ). Similar to degradation of cGAS, DENV and other related flaviviruses 137 proteolytically cleave STING using the viral protease complex NS2B3, blocking induction of signaling [45, 46] and identified UL31 as a potent inhibitor of pathway activation in cells. Using biochemistry 312 and cell biology, the authors show that UL31 binds cGAS and drives its dissociation from 313 DNA to block production of 2′3′-cGAMP. • Pathogens evade cytosolic DNA sensing using divergent and overlapping strategies to target 530 cGAS, 2′3′-cGAMP, and STING 531 532

• Studies of pathogen mechanisms of cGAS-STING evasion reveal new insights into cellular 533 regulation of immune activation 534 535

• Newly discovered regulatory features of cGAS-STING signaling suggest yet undiscovered 536 strategies which pathogens may employ for immune evasion 537 538 

Cyclic GMP-AMP synthase is a cytosolic DNA 211 sensor that activates the type I interferon pathway

Cyclic [G(2′,5′)pA(3′,5′)p] is the metazoan second messenger 214 produced by DNA-activated cyclic GMP-AMP synthase

The Innate Immune DNA Sensor cGAS Produces a 217

Cyclic GMP-AMP containing 220 mixed Phosphodiester linkages is an endogenous high-affinity ligand for STING

The authors acknowledge funding through the Richard and Susan Smith Family Foundation and 481 the Parker Institute for Cancer Immunotherapy, and apologize to those in the field whose work 482 was not cited in this short review due to space constraints. 483 484 Author Contributions: Review was written by J.B.E and P.J.K., figures were prepared by